A generic method for design of oligomer-specific antibodies.
Antibodies that preferentially and specifically target pathological oligomeric protein and peptide assemblies, as opposed to their monomeric and amyloid counterparts, provide therapeutic and diagnostic opportunities for protein misfolding diseases. Unfortunately, the molecular properties associated...
Enregistré dans:
Auteurs principaux: | Kristoffer Brännström, Malin Lindhagen-Persson, Anna L Gharibyan, Irina Iakovleva, Monika Vestling, Mikael E Sellin, Thomas Brännström, Ludmilla Morozova-Roche, Lars Forsgren, Anders Olofsson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/85bdb2aa8c704054b936e00b43b5987b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
par: Malin Lindhagen-Persson, et autres
Publié: (2010) -
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.
par: Kiran Yanamandra, et autres
Publié: (2011) -
The Swedish translation and cultural adaptation of the Measure of Moral Distress for Healthcare Professionals (MMD-HP)
par: Catarina Fischer-Grönlund, et autres
Publié: (2021) -
PrP(Sc)-specific antibodies with the ability to immunodetect prion oligomers.
par: Mourad Tayebi, et autres
Publié: (2011) -
A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
par: Ebrima Gibbs, et autres
Publié: (2019)